The ethics of neonatal research: A trialists' perspective

Area of Science:

• Neonatal medicine
• Clinical trials
• Evidence-based practice

Background:

• Neonatal physicians are committed to evidence-based medicine.
• Randomized trials are crucial for evaluating interventions in vulnerable populations.
• Previous trials have improved neonatal care and identified knowledge gaps.

Purpose of the Study:

• To advocate for and conduct randomized trials in preterm and critically ill infants.
• To improve the care and outcomes of neonates through rigorous research.
• To emphasize the ethical and essential nature of controlled clinical trials.

Main Methods:

• Conducting and promoting randomized controlled trials (RCTs).
• Focusing on preterm and critically ill infant populations.
• Employing randomization as the optimal strategy to minimize bias in therapy evaluation.

Main Results:

• RCTs have historically identified superior care practices for neonates.
• Trials have revealed therapies that are ineffective or potentially harmful.
• Neonatal RCTs have uncovered significant gaps in current medical knowledge.

Conclusions:

• Randomized trials are ethically sound and essential in neonatal medicine.
• Randomization is the gold standard for minimizing bias in treatment evaluation.
• Neonatal randomized trials can be safely conducted in collaboration with families.